Page last updated: 2024-08-22

pyrvinium and Carcinogenesis

pyrvinium has been researched along with Carcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amoreo, CA; Aria, V; Avvedimento, VE; Bardelli, A; Bosotti, R; Cardone, L; Carrella, D; Ciolli, L; Dattilo, R; di Bernardo, D; Iezzi, M; Isacchi, A; Loreni, F; Manni, I; Mottolese, M; Mutarelli, M; Papaccio, F; Sirci, F; Tumaini, B	1

Other Studies

1 other study(ies) available for pyrvinium and Carcinogenesis

Article	Year
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds. Oncotarget, 2016, Sep-13, Volume: 7, Issue:37 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Computational Biology; Drug Approval; Drug Repositioning; Female; Humans; Mammary Glands, Animal; Mice; Niclosamide; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrvinium Compounds; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction	2016

Article

Year

Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.

Oncotarget, 2016, Sep-13, Volume: 7, Issue:37

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Computational Biology; Drug Approval; Drug Repositioning; Female; Humans; Mammary Glands, Animal; Mice; Niclosamide; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrvinium Compounds; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction

2016